Connect with us

Media OutReach

The Functional Foods for Wellness Summit BKK 2025 concluded successfully in Bangkok, Thailand, on January 16th

Published

on

BANGKOK, THAILAND – Media OutReach Newswire – 17 January 2025 – The Functional Foods for Wellness Summit BKK 2025 concluded successfully in Bangkok, Thailand, on January 16th. The summit received strong support from international organizations such as the International Probiotics Association (IPA), the Health Food Supplement Association (HFSA), the Malaysia Dietary Supplement Association (MADSA), the Japan Health Business Media, the Turkish Food Safety Association, and the Expert Nutraceutical Advocacy Council (ENAC®). Over a hundred and fifty experts, industry association representatives, and corporate executives engaged in the health food industry from countries and regions including China, Thailand, Japan, Canada, South Korea, Australia, Malaysia, Singapore, Indonesia, India, and Turkey actively participated in this international industry event.

More than twenty experts and scholars from organizations such as the International Probiotics Association, Health Food Supplement Association, Morinaga, BYHEALTH, Bart, Kaneka Ubiquinol™, Synbio Tech, Biotropics, Kyowa Hakko Bio, Mengniu Dairy and others provided in-depth insights on topics of industry-wide interest, including health food regulatory policies, product innovation and research and development, and market development trends. Keynote speeches on popular topics such as “HMOs: Supporting Through Every Life Stage” also sparked enthusiastic discussions among attendees.

Dr. Eri Nakazaki, Manager of Research and Business Development at Kirin Holdings Company, Limited/Kyowa Hakko Bio, presented groundbreaking research on Human Milk Oligosaccharides (HMOs) with a focus on their health benefits on the Asian population at FFWS 2025. She remarked, “We look forward to continuing to contribute to the development of nutritional science and provide products that support the health of as many people as possible.”

To recognize outstanding achievements in the field of functional food, the organizing committee presented 21 trophies and certificates to 11 companies during the awards ceremony on the first evening of the summit.

Annual Healthy Aging Ingredient Award-Kaneka Ubiquinol™ -Kaneka Corporation

Kaneka Ubiquinol™ is supported by 100+ studies, 80+ patents and 45 years of research and is scientifically proven to support mitochondrial function, cardiovascular health and the maintenance of healthy cardiovascular function, supporting blood vessel health and healthy LDL cholesterol, cognition, menopause, male and female fertility, energy production for healthy aging and optimal wellbeing.

Annual Product Form Innovation Award-BYHEALTH RELAX & SLEEP DIETARY SUPPLEMENT-BYHEALTH

Annual Technological Innovation Pioneer Award-BYHEALTH WOMEN’S CARE & LIVER CLEANSE -BYHEALTH

Annual Joint Care Product Excellence Award-Highflex Glucosamine Chondroitin Sulfate Collagen Peptide Tablet –BYHEALTH

Annual Joint Health Product Innovation Award Highflex Glucosamine Chondroitin Sulfate Calcium Tablet-BYHEALTH

Annual Ingredient for Weight Management Award-Bifidobacterium breve B-3-Morinaga

Annual Ingredient for Immune Function Award -LAC-Shield™ (heat-killed Lacticaseibacillus paracasei MCC1849-Morinaga

Annual Women’s Health Product Award ->Your< UTI Free Orosticks-PharmaLinea

Annual Bone and Joint Health Product Award->Your< Back Pain Capsules-PharmaLinea

Annual Bone and Joint Health Product Award->Your< Arthro Ease Capsules-PharmaLinea

Annual Vision & Eye Health Ingredient Award-Lute-gen®-Bio-gen Extracts

Annual Ingredient for Women’s Health Award-Nu-Femme®-biotropics

Annual Ingredient for Cardiovascular Health Award-BBR4401®-ILDONG Bioscience

Annual Sugar Control Dairy New Product Award-Mengniu Yourui AnTangDun Formula Milk Powder-Mengniu

Annual Middle-aged and Senior Mobility Nutrition Product Award-Mengniu Yourui Guli Golden Formula Milk Powder-Mengniu

Annual Innovation in Childhood Nutrition Award-Mengniu One Metre Eighty-Eight Children Growth Formula Milk Powder-Mengniu

Annual Weight Management Product Excellence Award-Mengniu Slimline White Kidney Bean Extract Probiotic Skim Milk Powder-Mengniu

Annual Youth Brain Nutrition Product Excellence Award-Mengniu Huicongming Native DHA Student Milk Powder-Mengniu

Annual Oral Beauty Product Award-Cenovis Collagen Vitamin Jelly-Opella Healthcare

Annual Gut Health Product Award-Enterogermina Gut Defense-Opella Healthcare

Annual Gut Health Ingredient Award-LychOtics™-Sirio Pharma

After the eveht, representatives from companies and associations such as Bart, the Turkish Food Safety Association, the International Probiotics Association, and Biotropics Malaysia all expressed their honor to be invited to this event. They also thanked the organizers for their hard work in providing a diverse and professional communication platform for participants from various fields of the industry. The guests’ sharing was both theoretically profound and rich in practical experience, bringing a lot of inspiration to the attendees. At the same time, they called on more companies and associations to participate in the next event.

The organizer, Lampten Information and Consulting, stated that they will confirm and announce the date and venue for the 2026 Functional Foods for Wellness Summit later this year.

The issuer is solely responsible for the content of this announcement.

Media OutReach

Global Wellness Forum 2026 Set for June 23 in Kuala Lumpur as Malaysia’s Nutraceutical Industry Embarks on Next-Gen Transformation

Published

on

KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 16 June 2026 – Malaysia’s wellness market is moving beyond traditional competition over ingredients, dosage, and pricing toward product-format experience, sustained use, and differentiated innovation. The Global Wellness Consumer & Product Trends Forum 2026 will hold a forum on June 23, 2026, in Kuala Lumpur. Under the theme “Defining the Next Generation of Health Industry,” the event will bring together Malaysian trade associations, leading distribution channels, and Taiwanese R&D teams to jointly explore market opportunities.

As a core component, James Pereira, general manager of MADSA, will share insights on Malaysian health industry regulations. Adrian Toh, CEO & Executive Director of R Pharmacy, will provide frontline retail channel observations regarding shifting consumer demands. Alex Liao, General Manager of Welbloom Bio-Tech, will represent Taiwan to share how format innovation effectively responds to brand differentiation, consumption experiences, and market compliance needs.

Faced with brands’ attention toward differentiated experiences, Welbloom Bio-Tech will showcase its proprietary, Halal-certified FRESH-Jelly® technology on-site, demonstrating the innovative application to make supplements more food-like. Through ingredient payload capacities, zero- or low-sugar designs, and customized flavor development, FRESH-Jelly® allows supplements to maintain functionality while becoming more enjoyable to consume regularly, providing Malaysian brands with a distinctive option beyond capsules and tablets.

With the rapid rise of Malaysia’s wellness consumer market, its mature distribution channels and exceptional potential for regional expansion are accelerating the country’s growth as a critical hub for the Southeast Asian health industry. Welbloom Bio-Tech states that this forum is a bridging platform connecting Taiwan’s manufacturing capabilities with Malaysian market insights, aiming to unlock commercially viable partnerships for both regions.

The event is organized by The PAGE, co-organized by Welbloom Bio-Tech and SEAbizs, and supported by NTBSA, MATRADE, R Pharmacy, and MADSA.

Event Information】
Time: June 23, 2026, 09:30 – 14:00
Venue: The Zenith – Connexion Conference & Event Centre, Kuala Lumpur

Hashtag: #WelbloomBioTech

The issuer is solely responsible for the content of this announcement.

About Welbloom Bio-Tech

Welbloom Bio-Tech focuses on health supplement R&D, manufacturing, and dosage form innovation. Through forward-looking market foresight and robust R&D technologies, it provides one-stop services from formulation design and flavor development to manufacturing, assisting clients in Malaysia and Singapore to build highly competitive health supplements.

To learn more, please search “Welbloom” or click the link:

Continue Reading

Media OutReach

Doing Good Index 2026: Asia’s US$753 Billion Philanthropic Potential Remains Unrealized

Published

on

In the 2026 edition of its flagship policy report the Doing Good Index, the Centre for Asian Philanthropy and Society (CAPS) finds that Asia’s capacity to deploy private capital for social good is not keeping pace with its potential.

  • Asia’s social sector is under strain: 78% of the 2,166 social delivery organizations (SDOs) surveyed report insufficient domestic funding.
  • Asia is one of the fastest-growing regions for wealth creation, yet the policies and incentives needed to channel it toward social good are not keeping pace.
  • Singapore has become the first economy to enter the “Doing Excellent” category, demonstrating what alignment across regulations, tax incentives, government partnerships and efforts to create a culture of giving can achieve.
  • 84% of Asian SDOs surveyed apply the UN Sustainable Development Goals (SDGs) in their operations, pointing to their enduring value as a shared framework for coordination and collective action beyond 2030.

HONG KONG SAR – Media OutReach Newswire – 16 June 2026 – Asia’s social needs are intensifying, and official development assistance is declining. Yet, while the region’s wealth is growing dramatically, the policies, incentives and partnerships needed to channel private capital toward social good are not keeping pace. That is a key finding of the Doing Good Index 2026, the fifth edition of CAPS’s flagship policy report, which assesses the enabling environment for private social investment across 17 Asian economies.

The report finds that while the enabling environment for private social investment is in place across much of the region, its effectiveness remains uneven. Improvements in registration processes and accountability mechanisms have been accompanied by persistent barriers, including restrictions on foreign funding, regulatory complexity, and inconsistent government engagement. In many cases, policies exist on paper but are not fully implemented in practice, limiting their impact.

At the same time, although trust in SDOs remains high across the region, broader ecosystem conditions, such as media sentiment, talent pipelines, and institutional support, are showing signs of strain. 81% of SDOs struggle to secure unrestricted funds for their work, while 73% report difficulty recruiting staff, constraining the sector’s ability to turn trust into impact.

“Asia has the wealth, the will, and in many economies, the foundations of a strong enabling environment. What is needed now is concerted, aligned effort to bring them together. The potential is enormous,” said Ruth Shapiro, Co-Founder and CEO, Centre for Asian Philanthropy and Society.

Unlocking Asia’s US$753 Billion Philanthropic Potential

Even as Asia’s wealth continues to grow, the region faces significant and intensifying challenges across climate, education and health. Official development assistance is declining, and there is increasing pressure on domestic resources at precisely the moment demand for social services is rising.

If Asian economies were to contribute just 2% of GDP to philanthropy, as the United States does, it could generate an estimated US$753 billion annually for social good. That represents 15 times the official development assistance flowing into the region, and almost half the financing needed to hit the UN’s SDGs in Asia. But realizing that potential depends on strengthening the policies, incentives and partnerships that enable private capital to flow toward social good. The Doing Good Index 2026 finds that across much of Asia, those conditions are not yet in place.

“The world has changed dramatically, and Asia can no longer rely on others to address its social challenges. The Doing Good Index 2026 shows the region has the potential to meet this moment, but only if governments and philanthropists act together to build the conditions that make it possible,” said Ronnie Chan, Chairman, Centre for Asian Philanthropy and Society.

Singapore Shows What Alignment Can Achieve
Singapore has, for the first time, entered the top “Doing Excellent” category in the Doing Good Index 2026, reflecting years of deliberate effort to build a strong culture of philanthropy and civic engagement. Clear regulations, generous tax incentives, openness to foreign funding, and close collaboration between government and the social sector have created a strong enabling environment.

Singapore’s achievement demonstrates that when regulations, fiscal policy, ecosystem conditions and procurement work in concert, the outcomes are stronger. While no two economies will follow the same path, Singapore’s experience highlights the conditions that matter, such as the active promotion and alignment of philanthropy and giving across the whole of society.

The SDGs: Falling Short but Still Relevant in Asia
In the run-up to 2030, global progress toward the SDGs has fallen short of ambition, and Asia is no exception. Yet the Doing Good Index 2026 finds that 84% of SDOs continue to apply the SDGs in their work. Further, the rise of Environmental, Social and Governance (ESG) reporting has not displaced them, because most SDOs see the two frameworks as complementary rather than competing.

As the deadline approaches, the Index points to their enduring value not as a target but as a shared framework for strategy, coordination and collective action in the years ahead.

Other Findings from the Report

  • Talent shortages persist for Asia’s social sector: more than 70% of SDOs face difficulty recruiting and retaining staff across Asia.
  • AI adoption is happening, but usage remains limited: only 13% of surveyed SDOs report using AI regularly.
  • 39% of SDOs say claiming tax benefits is difficult, suggesting administrative barriers may be limiting the impact of existing incentives for giving.

Hashtag: #CAPS #DoingGood #PrivateCapital #PublicGood #Philanthropy #Impact

The issuer is solely responsible for the content of this announcement.

About the Doing Good Index

Released biennially and now in its fifth edition, the Doing Good Index is CAPS’s flagship policy research that assesses the enabling environment for doing good in Asia: the systems, policies and practices that facilitate or constrain philanthropic giving and the deployment of this capital.

CAPS’s research team surveyed 2,166 social delivery organizations (SDOs) and conducted 132 interviews with sector experts across 17 Asian economies to provide a comparative, evidence-based view of where environments are supportive, where gaps persist, and how systems can be strengthened to better mobilize private resources for public good.

The Index looks at indicators under four sub-indexes: regulations, tax and fiscal policy, ecosystem, and government procurement, which provide an understanding of the specific measures economies have taken to catalyze philanthropic giving and promote social sector development.

Since its inception, the Index has been an essential resource for policymakers, philanthropists, and nonprofit leaders seeking to understand and improve the conditions for giving across the region.

For more information, and visit .

About the Centre for Asian Philanthropy and Society (CAPS)

Established in 2013 and working across more than 17 economies in Asia, the Centre for Asian Philanthropy and Society (CAPS) is a nonprofit organization committed to improving the quantity and quality of philanthropic and private giving throughout Asia. Our mission is to maximize private capital for public good, conducting research, advisory, convening and capacity building to engage philanthropists, foundations, family offices, corporates, government bodies, social sector organizations and experts on best practices, models, policies and strategies to facilitate private giving and social investment in the region. For more information, visit and .

Continue Reading

Media OutReach

Frost & Sullivan White Paper Names Phancy Rise vGPU a Tier 1 Leading Platform

Published

on

Rise vGPU + ModelHub Power China’s AI into the Heterogeneous Orchestration Era

HONG KONG SAR – Media OutReach Newswire – 15 June 2026 – Frost & Sullivan, a globally renowned growth consulting firm, has released its “2026 AI Infrastructure Orchestration Platform White Paper”. The report recognizes Phancy Group’s Rise vGPU as a Tier 1 Leading Platform, the highest maturity tier in heterogeneous GPU orchestration. Phancy’s ModelHub also achieved the highest Overall Score in the enterprise-grade model management platform evaluation. This marks a significant endorsement of Phancy’s technological capability in heterogeneous AI infrastructure.

According to the white paper, as large model applications scale rapidly, China’s AI industry is facing structural challenges stemming from multi-chip coexistence. These include hardware heterogeneity, fragmented software stacks, persistently low GPU utilization (generally below 30%), and rising model adaptation complexity — all of which have become major bottlenecks for enterprise-scale AI deployment.

The report highlights a fundamental shift in AI infrastructure competitiveness – moving away from “single-chip performance” toward “cluster-scale system coordination.” At this critical juncture, Phancy has positioned itself as a leader in advanced orchestration through its full-stack AI infrastructure platform, offering a proven solution to heterogeneous compute challenges and helping drive China’s AI industry from “compute accumulation” into a new era of “compute orchestration.”

Phancy Rise vGPU: Tier 1 Leading Platform

In its assessment of mainstream AI infrastructure platforms, Frost & Sullivan defined Tier 1 criteria across three core dimensions: heterogeneous support, fine-grained control, and production-grade execution. Phancy Rise vGPU meets all three standards and has been recognized as a Tier 1 Leading Platform.

Rise vGPU transforms AI infrastructure from fragmented, low-efficiency device-level management to a unified software-defined control plane. Its key technology breakthroughs include:

  • Comprehensive Heterogeneous Management: Unified onboarding and management across more than 10 mainstream GPU/NPU vendors, including NVIDIA, Ascend, Cambricon, Hygon, and others.
  • Ultra-Fine Resource Partitioning: Industry-leading sub-GPU level compute and MB-level memory granularity slicing.
  • Significant Utilization Improvement: Through safe oversubscription and time/space multiplexing, GPU utilization is increased from industry averages below 30% to 70%-90%.
  • Intelligent Precision Scheduling: Multi-dimensional scheduling algorithms based on priority, topology, load, and resource awareness to achieve optimal compute allocation.
  • Production-Grade SLA Assurance: The Deterministic Execution Layer delivers committed and auditable SLA guarantees for critical inference workloads.
  • Full Lifecycle Operability: Comprehensive monitoring, metering, and cost allocation capabilities that turn GPU resources into truly operable digital assets.

Model Hub: Highest Overall Score in Model Management Platform Evaluation

Beyond compute orchestration, the report underscores the strategic importance of enterprise-grade model management platforms. As a powerful complement to Rise vGPU, Phancy ModelHub enables enterprises to build a complete full-stack AI infrastructure — from compute to models and from resource scheduling to business delivery.

The white paper notes that Phancy ModelHub delivers leading performance in key areas such as Model & Chip Compatibility, Execution Stability & Performance, and Model-GPU Coordination & Scheduling, achieving the highest Overall Score. Through its unified model management and execution platform, ModelHub creates a seamless closed-loop process covering model onboarding, deployment optimization, inference services, and version governance — significantly lowering the barrier to model deployment and accelerating AI innovation.

Dr. Dai Wenyuan, Founder & CEO of Phancy, said: “The Frost & Sullivan white paper accurately captures the inflection point in AI infrastructure development. The recognition of Rise vGPU as a Tier 1 Leading Platform and ModelHub’s top Overall Score provide important authoritative validation of Phancy’s technology strategy and product strength. As a full-stack AI cloud service platform, Phancy believes the next wave of competitiveness in the AI industry will come from systematic improvements in compute orchestration efficiency. We will continue to focus on heterogeneous compute unified scheduling and model ecosystem operations, working closely with customers and industry partners to advance China’s AI industry from ‘compute accumulation’ to a true ‘compute orchestration’ era.”

Hashtag: #PhancyGroup

The issuer is solely responsible for the content of this announcement.

About Phancy Group

Phancy Group (6682.HK) is a leading full-stack AI cloud services platform, providing comprehensive solutions for the AI 2.0 era. Our offerings include Rise vGPU, ModelHub and SageAIOS, delivering efficient and scalable AI infrastructure with end-to-end capabilities. We provide a complete solution from heterogeneous compute resource management and optimization to the deployment of intelligent agent models. These solutions empower digital transformation across a wide range of industries, supporting our vision of building a large-scale and efficient “Token Factory.”

Guided by the mission of “AI for Everyone” and positioned as the “Navigator of AI,” Phancy Group is committed to becoming a global leader in Artificial General Intelligence.

Continue Reading

Trending